RE: Deal to be signed shortly. Significant cash payments3 Oct 2023 19:09
You got to be pretty stupid to suggest that price. Our market cap is 10 million. We have value with the deal coming, CLX and a fully set up lab. Who would not buy at 9/10p for a tiny amount of our market cap. Don't be so stupid and idiotic.
Valirx has no reason to do a cash raise at the moment with the deal being imminent. We have cash until Feb and they can even slow down the burn rate by reducing work on R and D if they had to. I know this as a fact.
We will receive almost 2 million over 12 months plus significant revenue from the lab which should reduce our cash burn rate to about 1 million max at the moment without the deal. We will also receive payments for consultancy fees relating to 201. It was confirmed in the RNS last week this will be paid with the signature. Also we have a few warrants at 14p and 22p Cenkos will likely take the 1 million pound warrants. We will therefore be cash positive.
The deal is extremely likely to come soon. They will not leave a large gap between presentation, Tweet, website so it is coming very soon I suspect within a few days.
201 is not priced in. We could open at 25,30p and then double from that price. Downside is very, very minimal and temporary but upside here is anything to around 70p with a 90 plus percent chance of the deal coming first or some lab contracts.